Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ARIX

Arix Bioscience (ARIX)

Arix Bioscience Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:ARIX
FechaHoraFuenteTítuloSímboloCompañía
13/02/202402:00RNS Regulatory NewsLondon Stock Exchange Notice Cancellation - Arix Bioscience plcLSE:ARIXArix Bioscience Plc
12/02/202406:53Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience shares suspended ahead of RTW takeoverLSE:ARIXArix Bioscience Plc
12/02/202406:00EQS Regulatory NewsScheme EffectiveLSE:ARIXArix Bioscience Plc
12/02/202401:00EQS Regulatory NewsSuspension of Trading in SharesLSE:ARIXArix Bioscience Plc
07/02/202405:30EQS Regulatory NewsTransaction UpdateLSE:ARIXArix Bioscience Plc
29/01/202406:15EQS Regulatory NewsResults of First General MeetingLSE:ARIXArix Bioscience Plc
24/01/202411:30EQS Regulatory NewsHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
23/01/202401:00EQS Regulatory NewsUpdate on the Scheme and Publication of Notice of Second General MeetingLSE:ARIXArix Bioscience Plc
22/01/202410:22Alliance NewsAlliance NewsIN BRIEF: RTW Biotech completes Arix investment in takeover run-upLSE:ARIXArix Bioscience Plc
22/01/202401:00EQS Regulatory NewsUpdate on the Scheme and Resignation of DirectorsLSE:ARIXArix Bioscience Plc
19/01/202405:29Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon saleLSE:ARIXArix Bioscience Plc
19/01/202401:01EQS Regulatory NewsFinancial update on Harpoon Therapeutics acquisition by Merck (MSD)LSE:ARIXArix Bioscience Plc
19/01/202401:00EQS Regulatory NewsUnaudited NAV for December 2023LSE:ARIXArix Bioscience Plc
08/01/202411:15EQS Regulatory NewsPortfolio company Harpoon Therapeutics to be acquired by Merck (MSD)LSE:ARIXArix Bioscience Plc
05/01/202401:00EQS Regulatory NewsPublication of Circular and RTW Bio ProspectusLSE:ARIXArix Bioscience Plc
22/12/202305:00UK RegulatoryUpdate regarding timing of Proposed Scheme of ReconstructionLSE:ARIXArix Bioscience Plc
13/12/202301:00UK RegulatoryUnaudited NAV for November 2023LSE:ARIXArix Bioscience Plc
08/12/202301:00UK RegulatoryPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass TrialLSE:ARIXArix Bioscience Plc
13/11/202310:00UK RegulatoryCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
10/11/202302:00UK RegulatoryPortfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
10/11/202301:00UK RegulatoryPDMR Notification & Director ShareholdingLSE:ARIXArix Bioscience Plc
08/11/202301:00UK RegulatoryUnaudited NAV for October 2023LSE:ARIXArix Bioscience Plc
01/11/202311:30UK RegulatoryPortfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102LSE:ARIXArix Bioscience Plc
01/11/202307:19Alliance NewsAlliance NewsRTW Biotech agrees "immediately accretive" Arix Bioscience takeoverLSE:ARIXArix Bioscience Plc
01/11/202302:06UK RegulatoryRTW Biotech Opportunities Ltd RTW Biotech to acquire Arix Bioscience's assetsLSE:ARIXArix Bioscience Plc
25/10/202315:55Alliance NewsAlliance NewsTRADING UPDATES: Gran Tierra completes offers, Pensana wins grantLSE:ARIXArix Bioscience Plc
24/10/202301:00UK RegulatoryPortfolio company Harpoon Therapeutics announces up to USD150 million private placementLSE:ARIXArix Bioscience Plc
06/10/202301:00UK RegulatoryUnaudited NAV for September 2023LSE:ARIXArix Bioscience Plc
27/09/202304:40Alliance NewsAlliance NewsArix Bioscience boosts net value, CEO jumping ship for PureTech HealthLSE:ARIXArix Bioscience Plc
27/09/202301:01UK RegulatoryInterim Results for the Six Months Ended 30 June 2023LSE:ARIXArix Bioscience Plc
 Showing the most relevant articles for your search:LSE:ARIX

Su Consulta Reciente

Delayed Upgrade Clock